vs

Side-by-side financial comparison of LINCOLN EDUCATIONAL SERVICES CORP (LINC) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($225.6M vs $142.9M, roughly 1.6× LINCOLN EDUCATIONAL SERVICES CORP). Organogenesis Holdings Inc. runs the higher net margin — 19.4% vs 8.9%, a 10.5% gap on every dollar of revenue. On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs 19.7%). Organogenesis Holdings Inc. produced more free cash flow last quarter ($34.8M vs $25.0M). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs 17.6%).

Lincoln Tech is an American group of for-profit postsecondary vocational institutions headquartered in Parsippany, New Jersey with campuses in Colorado, Connecticut, Georgia, Illinois, Indiana, Maryland, New Jersey, New York, Pennsylvania, Rhode Island, Tennessee, and Texas. Each campus is owned and operated by Lincoln Educational Services Corporation, a provider of career-oriented post-secondary education.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

LINC vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.6× larger
ORGO
$225.6M
$142.9M
LINC
Growing faster (revenue YoY)
ORGO
ORGO
+58.4% gap
ORGO
78.1%
19.7%
LINC
Higher net margin
ORGO
ORGO
10.5% more per $
ORGO
19.4%
8.9%
LINC
More free cash flow
ORGO
ORGO
$9.8M more FCF
ORGO
$34.8M
$25.0M
LINC
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
17.6%
LINC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LINC
LINC
ORGO
ORGO
Revenue
$142.9M
$225.6M
Net Profit
$12.7M
$43.7M
Gross Margin
62.3%
Operating Margin
12.4%
28.1%
Net Margin
8.9%
19.4%
Revenue YoY
19.7%
78.1%
Net Profit YoY
85.9%
469.5%
EPS (diluted)
$0.41
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LINC
LINC
ORGO
ORGO
Q4 25
$142.9M
$225.6M
Q3 25
$141.4M
$150.9M
Q2 25
$116.5M
$101.0M
Q1 25
$117.5M
$86.7M
Q4 24
$119.4M
$126.7M
Q3 24
$114.4M
$115.2M
Q2 24
$102.9M
$130.2M
Q1 24
$103.4M
$110.0M
Net Profit
LINC
LINC
ORGO
ORGO
Q4 25
$12.7M
$43.7M
Q3 25
$3.8M
$21.6M
Q2 25
$1.6M
$-9.4M
Q1 25
$1.9M
$-18.8M
Q4 24
$6.8M
$7.7M
Q3 24
$4.0M
$12.3M
Q2 24
$-682.0K
$-17.0M
Q1 24
$-214.0K
$-2.1M
Gross Margin
LINC
LINC
ORGO
ORGO
Q4 25
62.3%
Q3 25
59.5%
Q2 25
59.8%
Q1 25
59.7%
72.6%
Q4 24
62.2%
75.5%
Q3 24
58.0%
76.7%
Q2 24
55.7%
77.6%
Q1 24
58.4%
73.9%
Operating Margin
LINC
LINC
ORGO
ORGO
Q4 25
12.4%
28.1%
Q3 25
4.4%
13.7%
Q2 25
2.5%
-12.5%
Q1 25
2.9%
-30.9%
Q4 24
9.2%
8.1%
Q3 24
5.1%
5.4%
Q2 24
-1.1%
-10.7%
Q1 24
-0.4%
-3.5%
Net Margin
LINC
LINC
ORGO
ORGO
Q4 25
8.9%
19.4%
Q3 25
2.7%
14.3%
Q2 25
1.3%
-9.3%
Q1 25
1.7%
-21.7%
Q4 24
5.7%
6.1%
Q3 24
3.5%
10.7%
Q2 24
-0.7%
-13.1%
Q1 24
-0.2%
-1.9%
EPS (diluted)
LINC
LINC
ORGO
ORGO
Q4 25
$0.41
$0.31
Q3 25
$0.12
$0.11
Q2 25
$0.05
$-0.10
Q1 25
$0.06
$-0.17
Q4 24
$0.22
$0.05
Q3 24
$0.13
$0.09
Q2 24
$-0.02
$-0.13
Q1 24
$-0.01
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LINC
LINC
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$28.5M
$93.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$199.7M
$300.1M
Total Assets
$493.2M
$598.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LINC
LINC
ORGO
ORGO
Q4 25
$28.5M
$93.7M
Q3 25
$13.5M
$63.7M
Q2 25
$16.7M
$73.1M
Q1 25
$28.7M
$110.0M
Q4 24
$59.3M
$135.6M
Q3 24
$54.0M
$94.3M
Q2 24
$67.0M
$89.9M
Q1 24
$68.6M
$88.6M
Total Debt
LINC
LINC
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Q1 24
$65.2M
Stockholders' Equity
LINC
LINC
ORGO
ORGO
Q4 25
$199.7M
$300.1M
Q3 25
$185.9M
$255.1M
Q2 25
$180.7M
$233.2M
Q1 25
$177.8M
$242.9M
Q4 24
$178.3M
$262.9M
Q3 24
$170.0M
$278.5M
Q2 24
$164.9M
$263.5M
Q1 24
$164.5M
$278.0M
Total Assets
LINC
LINC
ORGO
ORGO
Q4 25
$493.2M
$598.7M
Q3 25
$466.9M
$509.8M
Q2 25
$447.3M
$461.1M
Q1 25
$427.4M
$467.4M
Q4 24
$436.6M
$497.9M
Q3 24
$404.0M
$446.3M
Q2 24
$366.4M
$443.2M
Q1 24
$355.2M
$458.5M
Debt / Equity
LINC
LINC
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LINC
LINC
ORGO
ORGO
Operating Cash FlowLast quarter
$43.5M
$39.4M
Free Cash FlowOCF − Capex
$25.0M
$34.8M
FCF MarginFCF / Revenue
17.5%
15.4%
Capex IntensityCapex / Revenue
13.0%
2.1%
Cash ConversionOCF / Net Profit
3.43×
0.90×
TTM Free Cash FlowTrailing 4 quarters
$-27.3M
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LINC
LINC
ORGO
ORGO
Q4 25
$43.5M
$39.4M
Q3 25
$23.9M
$3.1M
Q2 25
$299.0K
$-32.9M
Q1 25
$-8.4M
$-19.9M
Q4 24
$30.3M
$10.9M
Q3 24
$5.6M
$8.7M
Q2 24
$8.3M
$4.7M
Q1 24
$-14.9M
$-10.2M
Free Cash Flow
LINC
LINC
ORGO
ORGO
Q4 25
$25.0M
$34.8M
Q3 25
$2.0M
$844.0K
Q2 25
$-26.1M
$-36.5M
Q1 25
$-28.3M
$-23.6M
Q4 24
$5.5M
$7.6M
Q3 24
$-13.8M
$6.1M
Q2 24
$-2.7M
$2.9M
Q1 24
$-16.6M
$-12.4M
FCF Margin
LINC
LINC
ORGO
ORGO
Q4 25
17.5%
15.4%
Q3 25
1.4%
0.6%
Q2 25
-22.4%
-36.1%
Q1 25
-24.1%
-27.2%
Q4 24
4.6%
6.0%
Q3 24
-12.0%
5.3%
Q2 24
-2.6%
2.2%
Q1 24
-16.1%
-11.3%
Capex Intensity
LINC
LINC
ORGO
ORGO
Q4 25
13.0%
2.1%
Q3 25
15.5%
1.5%
Q2 25
22.7%
3.6%
Q1 25
16.9%
4.2%
Q4 24
20.8%
2.7%
Q3 24
16.9%
2.2%
Q2 24
10.7%
1.4%
Q1 24
1.6%
2.0%
Cash Conversion
LINC
LINC
ORGO
ORGO
Q4 25
3.43×
0.90×
Q3 25
6.29×
0.14×
Q2 25
0.19×
Q1 25
-4.31×
Q4 24
4.43×
1.43×
Q3 24
1.42×
0.71×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LINC
LINC

Transferred Over Time$136.0M95%
Transferred At Point In Time$6.9M5%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons